Promoting vascularization for tissue engineering constructs: current strategies focusing on HIF-regulating scaffolds
- 7 January 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 19 (2) , 105-118
Abstract
Introduction: Vascularization remains one of the greatest yet unmet challenges in tissue engineering. When engineered tissues are scaled up to therapeutically relevant dimensions, their demand of oxygen and nutrients can no longer be met by diffusion. Thus, there is a need for perfusable vascular structures. Hypoxia-inducible factors (HIF) act as transcriptional oxygen sensors and regulate a multitude of genes involved in adaptive processes to hypoxia, including angiogenesis. Thus, targeting HIFs is a promising strategy to induce vascularization of engineered tissues. Areas covered: Here we review current vascularization strategies and summarize the present knowledge regarding activation of HIF signaling by ions, iron chelating agents, α-Ketoglutarate (αKG) analogues, and the lipid-lowering drug simvastatin to induce angiogenesis. Specifically, we focus on the incorporation of HIF-activating agents into biomaterials and scaffolds for controlled release. Expert opinion: Vascularization of tissue constructs through activation of upstream regulators of angiogenesis offers advantages but also suffers from drawbacks. HIFs can induce a complete angiogenic program; however, this program appears to be too slow to vascularize larger constructs before cell death occurs. It is therefore crucial that HIF-activation is combined with cell protective strategies and prevascularization techniques to obtain fully vascularized, vital tissues of therapeutically relevant dimensions.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (326998133 – TRR 225)
This publication has 147 references indexed in Scilit:
- Regulation of VEGF expression by HIF-1α in the femoral head cartilage following ischemia osteonecrosisScientific Reports, 2012
- Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissuesNature Materials, 2012
- Sustaining Neovascularization of a Scaffold Through Staged Release of Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-BBTissue Engineering Part A, 2012
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Scaffold-free vascular tissue engineering using bioprintingBiomaterials, 2009
- Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 ExpressionCirculation Research, 2009
- Copper Regulation of Hypoxia-Inducible Factor-1 ActivityMolecular Pharmacology, 2009
- Stabilization of HIF-1α is critical to improve wound healing in diabetic miceProceedings of the National Academy of Sciences, 2008
- Short Hairpin RNA Interference Therapy for Ischemic Heart DiseaseCirculation, 2008
- FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarctionProceedings of the National Academy of Sciences, 2006